Global Hyaluronidase Market Report By Type (Animal-derived Hyaluronidase, Synthetic Hyaluronidase), By Application (Dermatology, Chemotherapy, Ophthalmology, Plastic Surgery, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2020-2027

ID:VMR11214856
May 2021
Report Formats:

Global Hyaluronidase Market Overview
The key driver impacting the hyaluronidase market is the rapidly growing incidence of cancer. For instance, as per the WHO report, Globally, cancer is the second most leading cause of death, and it accounts for 9.6 million deaths in 2018. There are one in six deaths occurred due to cancer. The most common cancers include Breast cancer (about 2.09 million cases), Lung cancer (2.09 million cases), Colorectal (1.80 million cases), and Prostate (1.28 million cases).  Hyaluronidase enzyme plays an important role in cancer metastasis and therapy due to the utilization of enzyme-based substrates for noninvasive tumor imaging.  Moreover, favorable reimbursement policies rising number of people opting for non-surgical aesthetic procedures contribute to hyaluronidase's market growth in the coming years.

According to Value Market Research, the global hyaluronidase market size was valued at around USD 700 million in 2020 and is estimated to grow at a CAGR of about 8.5% during the forecast period 2021 to 2027.

The rising number of minimally invasive aesthetic surgeries is estimated to augment the hyaluronidase system's demand in the forecast period. For instance, as per the plastic surgery organization, Over 1.8 million cosmetic surgical procedures were performed in 2018. Among them, the top five were Breast augmentation (around 313,735 procedures, increased by 4% from 2017), Liposuction (approximately 258,558 procedures, increased by 5% from 2017), Nose reshaping ( about 213,780 procedures), Eyelid surgery (206,529 procedures), and Tummy tuck (130,081 procedures, same as 2017). There were 15.9 million cosmetic minimally-invasive procedures that took place in 2018. Among the total procedures, the top 5 were Botulinum Toxin Type A (about 7.44 million procedures, climb by 3% from 2017), Soft Tissue Fillers (around 2.68 million procedures, increased by 2% from 2017), Chemical Peel (1.38 million procedures, increased by 1% since 2017), Laser hair removal, and Microdermabrasion (709,413 procedures). However, adverse effects associated with hyaluronidases may hamper the market in the long run. Also, side effects such as rapid heartbeats, skin rashes, dizziness, and unusual weakness negatively impact the market. The current industry trends, such as the rising awareness regarding alteration of physical appearance and increasing penetration of hyaluronidase in correction procedures, are expected to offer new lucrative market opportunities for the key players.
 
The hyaluronidase market is vast, with many local and global players. The hyaluronidase market is extensive, with many regional and international players. The important market leaders follow several strategies to raise their market status, such as extending product portfolio, acquisitions, expanding product portfolio, contracts, amalgamation, contracts, acquisitions, product upgrades to enlarge their market share across the globe. The significant players studied in the report include Amphastar Pharmaceuticals, Inc., Halozyme, Inc., PrimaPharma, Inc., The Cooper Companies Inc., Bausch & Lomb Incorporated, Sun Pharmaceutical Industries Ltd., Shreya Life Sciences Pvt. Ltd, and STEMCELL Technologies Inc.

Global Hyaluronidase Market Share

Know more about this report: Download free sample

In this research report, the hyaluronidase market is segmented by type, application, and region.
 
Analysis by Type:
 
By type, the report is categorized into Animal-derived Hyaluronidase and Synthetic Hyaluronidase. The Animal-derived Hyaluronidase segment dominates the type segment with over 55% share in 2020. It is because most approved and commercialized brands, at present, are derived from animal sources, and the most commonly used animal sources are bovine and porcine products. Moreover, the animal-derived hyaluronidase market has witnessed a substantial number of product approvals, contributes to the massive demand for the Animal-derived Hyaluronidase segment in the coming years.
 
Analysis by Application:
 
By application, the report is categorized into Dermatology, Chemotherapy, Ophthalmology, Plastic Surgery, and Others. The Dermatology application segment dominates the application segment with over 30% share in 2020. It is due to the growing significance of hyaluronidase usage in dermatology. Moreover, the Hyaluronidase enzyme depolymerizes hyaluronic acid and enables enhanced permeability of connective tissue, contributes to the massive market demand for the Dermatology application segment in the forecast period.
                           
Analysis by Region:
 
In the regional outlook of the global hyaluronidase market, the North America region dominates globally with a 30% market share in the forecast period. It is due to the growing number of experimental procedures that offers an in-vitro evaluation of the biological availability of hyaluronidase and the presence of key players manufacturing these products. Moreover, the high adoption of advanced treatment options and a considerable number of dermatology clinics prescribing such treatments contribute to tremendous market growth across North America.
 
Market Segmentation covered in the Report:
By Type

  • Animal-derived Hyaluronidase
  • Synthetic Hyaluronidase

By Application

  • Dermatology
  • Chemotherapy
  • Ophthalmology
  • Plastic Surgery
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

METHODOLOGY

This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. 

If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.                

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . HYALURONIDASE – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Type
           3.7.2 By Application
           3.7.3 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL HYALURONIDASE MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Type
       6.4 Animal-derived Hyaluronidase Market by Regions
       6.6 Synthetic Hyaluronidase Market by Regions
 
7 . GLOBAL HYALURONIDASE MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Historical and Forecast Data
       7.3 Analysis by Application
       7.4 Dermatology Market by Regions
       7.5 Chemotherapy Market by Regions
       7.6 Ophthalmology Market by Regions
       7.7 Plastic Surgery Market by Regions
       7.8 Others Market by Regions
 
8 . GLOBAL HYALURONIDASE MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview, Historic and Forecast Data
           8.3.2. North America By Segment
           8.3.3. North America By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview, Historic and Forecast Data
           8.4.2. Europe by Segment
           8.4.3. Europe by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview, Historic and Forecast Data
           8.5.2. Asia Pacific by Segment
           8.5.3. Asia Pacific by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview, Historic and Forecast Data
           8.6.2. Latin America by Segment
           8.6.3. Latin America by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview, Historic and Forecast Data
           8.7.2. Middle East & Africa by Segment
           8.7.3. Middle East & Africa by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa
 
9 . COMPETITIVE LANDSCAPE OF THE HYALURONIDASE COMPANIES
       9.1. Hyaluronidase Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF HYALURONIDASE INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Amphastar Pharmaceuticals, Inc.
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Halozyme, Inc.
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. PrimaPharma, Inc.
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. The Cooper Companies Inc.
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Bausch & Lomb Incorporated
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Sun Pharmaceutical Industries Ltd.
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Shreya Life Sciences Pvt. Ltd
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. STEMCELL Technologies Inc.
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Type (USD MN)
  •  Animal-derived Hyaluronidase Market by Geography (USD MN)
  •  Synthetic Hyaluronidase Market by Geography (USD MN)
  •  Analysis Market by Application  (USD MN)
  •  Dermatology Market by Geography (USD MN)
  •  Chemotherapy Market by Geography (USD MN)
  •  Ophthalmology Market by Geography (USD MN)
  •  Plastic Surgery Market by Geography (USD MN)
  •  Others Market by Geography (USD MN)
  •  Global Hyaluronidase Market by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton

 
 LIST OF FIGURES
 

  •  Research Scope of Hyaluronidase Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Hyaluronidase Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Type
  •  Market Attractiveness Analysis by Application
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Type (USD MN)
  •  Animal-derived Hyaluronidase Market by Geography (USD MN)
  •  Synthetic Hyaluronidase Market by Geography (USD MN)
  •  Global Market Analysis by Application  (USD MN)
  •  Dermatology Market by Geography (USD MN)
  •  Chemotherapy Market by Geography (USD MN)
  •  Ophthalmology Market by Geography (USD MN)
  •  Plastic Surgery Market by Geography (USD MN)
  •  Others Market by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Company Market Share Analysis, 2020

 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials